Dustin S. Sjuts, President at Revance Therapeutics, Inc. (RVNC), sold 42,030 shares at $34.55 ($1.5M) on 2023-05-15, disclosed to the SEC on 2023-05-16.
Open-market sale of $1.5M RVNC by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.55 | 21,015 | $726K | 50.0% |
| 2 | $34.55 | 21,015 | $726K | 50.0% |
| Total | $34.55 avg | 42,030 | $1.5M | 100% |
| Filing → |
| RVNC | SELL | 2023-03-09 | $1.4M | — | Filing → |